• Beware! Abbott Laboratories (ABT) Issues Biosimilars Challenge More...
• Biodel Inc. (BIOD) Announces $18.5 Million Private Placement More...
• Xanodyne Pharmaceuticals, Inc. Sells Drug for $26 Million to Depomed, Inc. (DEPO) More...
• OXiGENE (OXGN) In-Licenses Rights to Promising Program for Neuroendocrine Tumors More...
• Marken (Formerly known as Marken Time Critical) Announces Global Advisory Board More...
• Mobius Photonics Welcomes New Board Member More...
• Scotland-based Innova Partnerships Ltd. Opens Boston Office More...
• Roche (RHHBY) Did Not Report Death, Illness in 80,000 Pts More...
• Merck & Co., Inc. (MRK) Recalls Vaccine After Accidental Release: FDA More...
• FDA Rejects Wider Use for Johnson & Johnson (JNJ), Bayer AG (BAY.F)'s Xarelto More...
• FDA Rejects Repligen Corporation (RGEN)'s Imaging Agent, Shares Drop More...
• Novartis AG (NVS), AstraZeneca PLC (AZN) Win EU Drug Okays; Pfizer Inc. (PFE) Loses Out More...
• Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX)'s Gaucher Drug Rejected by EU Regulator More...
• Alexza Pharmaceuticals, Inc. (ALXA) Resubmits Drug Application, Shares Soar More...
• Genentech (RHHBY) Says Perjeta Combination Increased Survival in Breast Cancer Patients More...
• Novo Nordisk A/S (NVO) Chooses to Move Semaglutide Into Phase III Trials More...
• Boston Therapeutics, Inc. Completes Enrollment in Phase ll Clinical Trial to Evaluate PAZ320 in Patients With Type 2 Diabetes More...
• Astex Pharmaceuticals (ASTX) Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients More...
• Cellceutix (CTIX) Approved by FDA to Proceed With Clinical Trials on Novel Cancer Drug More...
• Male Tea Drinkers "Face Increased Prostate Cancer Risk," Glasgow University Study More...
• How Early Birds are Happier Than Night Owls, University of Toronto Study More...
• Common Blood Pressure Drug Linked to Severe GI Problems, Mayo Clinic Study More...
• Dad's Brains Mean More to His Son's Success Than His Money, Brigham Young University Study More...
• Biodel Inc. (BIOD) Announces $18.5 Million Private Placement More...
• Xanodyne Pharmaceuticals, Inc. Sells Drug for $26 Million to Depomed, Inc. (DEPO) More...
• OXiGENE (OXGN) In-Licenses Rights to Promising Program for Neuroendocrine Tumors More...
• Gentris Corporation Partners with the Shanghai Institutes of Preventative Medicine More...
• Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc. (ESALF.PK) More...
• Marken (Formerly known as Marken Time Critical) Announces Global Advisory Board More...
• Mobius Photonics Welcomes New Board Member More...
• Scotland-based Innova Partnerships Ltd. Opens Boston Office More...
• Roche (RHHBY) Did Not Report Death, Illness in 80,000 Pts More...
• Merck & Co., Inc. (MRK) Recalls Vaccine After Accidental Release: FDA More...
• FDA Rejects Wider Use for Johnson & Johnson (JNJ), Bayer AG (BAY.F)'s Xarelto More...
• FDA Rejects Repligen Corporation (RGEN)'s Imaging Agent, Shares Drop More...
• Novartis AG (NVS), AstraZeneca PLC (AZN) Win EU Drug Okays; Pfizer Inc. (PFE) Loses Out More...
• Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX)'s Gaucher Drug Rejected by EU Regulator More...
• Alexza Pharmaceuticals, Inc. (ALXA) Resubmits Drug Application, Shares Soar More...
• Genentech (RHHBY) Says Perjeta Combination Increased Survival in Breast Cancer Patients More...
• Novo Nordisk A/S (NVO) Chooses to Move Semaglutide Into Phase III Trials More...
• Boston Therapeutics, Inc. Completes Enrollment in Phase ll Clinical Trial to Evaluate PAZ320 in Patients With Type 2 Diabetes More...
• Astex Pharmaceuticals (ASTX) Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients More...
• Cellceutix (CTIX) Approved by FDA to Proceed With Clinical Trials on Novel Cancer Drug More...
• Male Tea Drinkers "Face Increased Prostate Cancer Risk," Glasgow University Study More...
• How Early Birds are Happier Than Night Owls, University of Toronto Study More...
• Common Blood Pressure Drug Linked to Severe GI Problems, Mayo Clinic Study More...
• Dad's Brains Mean More to His Son's Success Than His Money, Brigham Young University Study More...
0 comments